[SaneVax: The FDA/CDC and government health officials around the globe are brushing off adverse events experienced after HPV vaccinations as ‘coincidence’ despite the fact that these ‘coincidences’ are occurring at more than twice the rate of other vaccines. In direct response to government’s lack of concern independent research scientist, Dr. Chandler Marrs has taken up the gauntlet. She has decided to conduct an independent survey to uncover the facts.
If you have had HPV vaccine injections, please take a few minutes to complete the survey below. Whether your experience with Gardasil or Cervarix has been good, bad, or ugly – medical consumers have a right to the truth. Please take a few minutes of your time to help reveal the truth.]
GARDASIL CERVARIX ONLINE STUDY CONTINUES – PARTICIPATE NOW
By Chandler Marrs, PhD
Controversy surrounds the HPV vaccines, Gardasil and Cervarix. Since their release, the vaccine industry, the media and medical societies have touted the safety and success of the vaccines in preventing or reducing HPV viral infections and thus, in preventing cervical cancer. Patient groups, mom’s of vaccine injured girls and anti-vaccine groups on the other hand, argue loudly that the rate and severity of serious adverse events are seriously under-reported by industry and the proof that these vaccines prevent or reduce cervical cancer is lacking. Even one of the lead developers of the vaccine, Diane Harper has come out against it.
Somewhere in the middle is the Vaccine Adverse Event Registry (VAERS), where only 1-10% of a very limited range adverse events are reported. Even with the limited reporting to VAERS, the severity and frequency of adverse events is growing and should not be ignored. Data collected from VAERS indicates a serious adverse event rate 4.3 per 100,000 doses of Gardasil. Serious adverse events are those that cause death or are life threatening, require hospitalization, cause persistent disability or incapacity and/or require medical treatment to prevent permanent impairment or damage. This is compared to a risk of cervical cancer of 7.9 per 100,000 and death from cervical cancer at 2.4 per 100,0000 cases in the US.
Considering the severity of the reported adverse reactions and the noted adverse events reporting rate of less than 10% of all cases, having more credible and complete data about true severity and prevalence of said reactions as well as more detailed data about who is at risk for those adverse events is critical.